Picture of RBC Life Sciences logo

RBCL RBC Life Sciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
Consumer CyclicalsHighly SpeculativeMicro Cap

Annual cashflow statement for RBC Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2010
December 31st
C2011
December 31st
2012
December 31st
2013
December 31st
2014
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line0.558-0.071-0.361-0.5-0.603
Depreciation
Deferred Taxes
Non-Cash Items0.080.039-0.4050.0230.002
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.736-0.2980.5180.418-0.462
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities0.5450.1250.4450.294-0.608
Capital Expenditures-0.163-0.35-0.805-0.267-1.07
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0070.0050.6250
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-0.156-0.345-0.18-0.267-1.07
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.111-0.169-0.182-0.215-0.212
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.248-0.3620.038-0.15-1.82